Elisabet Manasanch
Medical Oncology · Houston, TXNPI 1053518134
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $110,355 of the $129,414 with a category attached, or 85.3%. 16 manufacturers reported payments, led by Sanofi at 28.8% of the total. Reporting peaked in 2022 at $38,072 and has fallen 93.7% since, to $2,400 in 2025.
Across 104 payments — averaging $1244.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$37K
- GSK$34K
- Sanofi-aventis U.S. LLC$15K
- Adaptive Biotechnologies Corporation$14K
- Johnson & Johnson$6K
- Pfizer$6K
- plus $16K from 10 others
Across 196 payments — averaging $63,519 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$7.4M
- Sanofi US Services Inc.$3.8M
- GSK$809K
- Merck$281K
- Sanofi$186K
What the payments were for
- Consulting fees$110,35585%
- Speaking & faculty fees$12,37010%
- Travel & lodging$4,2093%
- Food & beverage$2,3812%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 32 | $37,283 |
| GSK | 23 | $34,310 |
| Sanofi-aventis U.S. LLC | 9 | $15,083 |
| Adaptive Biotechnologies Corporation | 4 | $13,500 |
| Johnson & Johnson | 8 | $6,385 |
| Pfizer | 5 | $6,366 |
| Secura Bio, Inc. | 7 | $4,003 |
| AstraZeneca | 1 | $3,300 |
| Legend Biotech USA Inc. | 2 | $2,930 |
| Janssen Global Services, LLC | 1 | $2,480 |
| E.r. Squibb & Sons, L.L.C. | 1 | $2,076 |
| Genentech, Inc. | 3 | $944 |
| Janssen Research & Development, LLC | 2 | $415 |
| Amgen | 4 | $281 |
| Janssen Scientific Affairs, LLC | 1 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$129,414 in reported general payments places this provider in the 85th percentile of 495 medical oncology providers in Texas.
Other medical oncology in Houston
- Roy HerbstHouston$1.9M
- Maen AbdelrahimHouston$999K
- John HeymachHouston$726K
- Putao CenHouston$720K
- Hagop KantarjianHouston$559K
- Ricardo AlvarezHouston$553K
- Eleni EfstathiouHouston$519K
- Srdan VerstovsekHouston$464K
- Guillermo Garcia-ManeroHouston$454K
- Jason WestinHouston$407K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.